Neogen Stock

Neogen EV/EBIT

The EV/EBIT (Enterprise Value to EBIT) of Neogen (NEOG) as of Jul 24, 2026 is 252.63. In the previous year, EV/EBIT (Enterprise Value to EBIT) was 30.74 — a change of 721.93% (higher).

EV/EBIT

252.63

YoY

721.93%

Last updated:

EV/EBIT (Enterprise Value to EBIT) of Neogen is 2026 252.63 . EV/EBIT (Enterprise Value to EBIT) of Neogen was 2025 30.74 . It decreases by 721.93% higher compared to the previous year.

The Neogen EV/EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PRICE-TO-EBIT
Date
PRICE-TO-EBIT
Jan 1, 2019
50.52 base
Jan 1, 2020
62.53 base
Jan 1, 2021
66.20 base
Jan 1, 2022
57.22 base
Jan 1, 2023
116.01 base
Jan 1, 2024
34.00 base
Jan 1, 2025
161.33 base
Jan 1, 2026 (e)
15.29 base
YEARPRICE-TO-EBIT
2026 est 15.29
2025 161.33
2024 34.00
2023 116.01
2022 57.22
2021 66.20
2020 62.53
2019 50.52
2018 42.29
2017 49.34
2016 44.80
2015 40.30
2014 42.73
2013 41.97
2012 32.60
2011 20.36
2010 36.23
2009 26.54
2008 20.81
2007 29.09
2006 19.55
Access this data via the Eulerpool API

Neogen Valuation

Details

Historical Valuation Multiples

Price-to-Earnings Ratio (P/E)

The P/E ratio divides Neogen's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates Neogen's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots Neogen's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if Neogen grows earnings faster than its peers.

Neogen Stock analysis

What does Neogen do? Neogen Corp is a leading provider of food safety and animal health solutions based in Lansing, Michigan, USA. The company was founded in 1982 by James Herbert and initially focused on the development and manufacturing of rapid tests for the dairy industry. Since then, Neogen has become an internationally operating company with over 25 subsidiaries and 1,800 employees. Neogen's business model is based on providing solutions for safe and healthy food supply and animal husbandry. The company operates in two main divisions: Food Safety and Animal Safety. Within these divisions, Neogen offers a wide range of test kits, diagnostic tools, information management software, and other products that help minimize the risk of food poisoning and improve the health of livestock. In the Food Safety division, Neogen offers a variety of test kits that allow food producers and retailers to quickly and easily detect various types of contaminants in food. These include tests for salmonella, E. coli, listeria, and mycotoxins. The company also provides tools for monitoring water quality and verifying cleaning and disinfection processes in food processing plants. In the Animal Safety division, Neogen also offers an extensive range of diagnostic tools to improve the health of livestock. The tests include infectious diseases such as brucellosis, BSE (mad cow disease), mastitis, and leukemia. Additionally, Neogen provides tools for animal identification and animal health data management. Neogen has also specialized in the development of technologies to improve animal health and nutrition, such as probiotics and supplements for livestock. Another focus of Neogen is the development of information management software that enables food producers and retailers to streamline the process of food safety and quality. The software allows companies to track tests, analyze data, and implement best practices to minimize the risk of food poisoning. In recent years, Neogen has also increasingly focused on the global market, especially the Asian market. The company has subsidiaries in various parts of the world, including Europe, Latin America, and Asia. Neogen works closely with local regulatory authorities to offer its products in accordance with local requirements. In conclusion, Neogen Corp is a leading provider of food safety and animal health solutions, focusing on the development and manufacturing of test kits, diagnostic tools, and information management software. The company has experienced impressive growth in recent decades and is now operating internationally. With its commitment to safe and healthy food supply and animal husbandry, Neogen sets industry standards. Neogen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Neogen stock

EV/EBIT (Enterprise Value to EBIT) of Neogen is 252.63 in 2026.

Access this data via the Eulerpool API

Valuation — Neogen

All Key Metrics — Neogen